# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 49

Extent: E+W+S+N.I.

For regulation 66 (amendment of regulation 60 (conditions of UK marketing authorisation: exceptional circumstances)) substitute—
“66 In regulation 60—
(a) after “UK marketing authorisation” in each place it occurs (including the heading to the regulation) insert “ or parallel import licence ”;
(b) after “the authorisation” in each place it occurs insert “ or licence ”;
(c) in paragraph (3), after “an authorisation” insert “ or licence ”;
(d) for paragraph (9) substitute—
“(9) The licensing authority must notify the EMA of any UKMA(NI) or UKMA(UK) that it has granted subject to a condition included in accordance with this regulation.”;
(e) in paragraph (10), after “a marketing authorisation” insert “ or licence ”.”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/49 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-49
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.